
News|Articles|September 1, 2004
Atorvastatin associated with modest but clinically apparent improvement in RA symptoms
Investigators in the Trial of Atorvastatin in Rheumatoid Arthritis (TARA) assessed whether statins would reduce inflammatory symptoms in patients with RA. Patients with RA (N=116) were randomized in the double-blind, placebo-controlled trial to receive 40 mg of atorvastatin or placebo in addition to their current disease-modifying antirheumatic drug (DMARD) therapy.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA issues third rejection of bevacizumab to treat wet AMD
2
Predictions for 2026 from Lucille Accetta, RPh, M.P.H., MBA, A.J. Loiacono and Allan Pannier, Pharm.D. MBA
3
Predictions for 2026 from Tracy Baroni Allmon, Sharon Faust, Mike Kolodij, and others
4
Predictions for 2026 from Marci Chodroff, M.D., Jeffrey Casberg, RPh, M.S., and others
5




















































